UFF
USA Financial Formulas Portfolio holdings
AUM
$586M
1-Year Return
13.49%
This Quarter Return
+0.65%
1 Year Return
+13.49%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$636M
AUM Growth
-$6.66M
(-1%)
Cap. Flow
-$10.2M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
80.47%
Holding
370
New
114
Increased
45
Reduced
127
Closed
84
Top Buys
| 1 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
$79.6M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
$77.2M |
| 3 |
iShares US Real Estate ETF
IYR
|
$74.6M |
| 4 |
Xcel Energy
XEL
|
$2.37M |
| 5 |
Gilead Sciences
GILD
|
$1.54M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$82.4M |
| 2 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
$77.5M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$73.8M |
| 4 |
NVIDIA
NVDA
|
$3.09M |
| 5 |
Broadcom
AVGO
|
$2.92M |
Sector Composition
| 1 | Financials | 3.39% |
| 2 | Industrials | 2.85% |
| 3 | Technology | 2.6% |
| 4 | Utilities | 2% |
| 5 | Communication Services | 1.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Tecnoglass
TGLS
$3.42B
| $25.7K | ﹤0.01% |
+324
| New | +$25.7K |
|
252
Adtalem Global Education
ATGE
$4.83B
| $25.6K | ﹤0.01% |
+282
| New | +$25.6K |
|
|
NAGE
253
Niagen Bioscience, Inc. Common Stock
NAGE
$750M
| $25.5K | ﹤0.01% |
+4,798
| New | +$25.5K |
|
254
TTM Technologies
TTMI
$4.93B
| $25.3K | ﹤0.01% |
+1,021
| New | +$25.3K |
|
255
Enova International
ENVA
$3.01B
| $25K | ﹤0.01% |
261
-642
| -71% | -$61.6K |
|
256
Carpenter Technology
CRS
$12.3B
| $24.8K | ﹤0.01% |
146
-16
| -10% | -$2.72K |
|
257
Mueller Water Products
MWA
$4.19B
| $24K | ﹤0.01% |
1,066
-63
| -6% | -$1.42K |
|
258
IMAX
IMAX
$1.6B
| $23.7K | ﹤0.01% |
+925
| New | +$23.7K |
|
259
FB Financial Corp
FBK
$2.89B
| $23.5K | ﹤0.01% |
+457
| New | +$23.5K |
|
260
Group 1 Automotive
GPI
$6.26B
| $23.2K | ﹤0.01% |
+55
| New | +$23.2K |
|
261
CRA International
CRAI
$1.28B
| $22.5K | ﹤0.01% |
120
-218
| -64% | -$40.8K |
|
262
Independence Realty Trust
IRT
$4.22B
| $22.1K | ﹤0.01% |
1,114
-36
| -3% | -$714 |
|
263
Dorman Products
DORM
$5B
| $22K | ﹤0.01% |
170
-342
| -67% | -$44.3K |
|
264
Itron
ITRI
$5.51B
| $21.7K | ﹤0.01% |
+200
| New | +$21.7K |
|
265
LeMaitre Vascular
LMAT
$2.21B
| $21.7K | ﹤0.01% |
235
-408
| -63% | -$37.6K |
|
266
Catalyst Pharmaceutical
CPRX
$2.48B
| $21.6K | ﹤0.01% |
+1,037
| New | +$21.6K |
|
267
Cactus
WHD
$2.93B
| $21.5K | ﹤0.01% |
+369
| New | +$21.5K |
|
268
Sabra Healthcare REIT
SBRA
$4.56B
| $20.8K | ﹤0.01% |
+1,203
| New | +$20.8K |
|
|
CSW
269
CSW Industrials, Inc.
CSW
$4.46B
| $20.1K | ﹤0.01% |
57
-269
| -83% | -$94.9K |
|
270
CareTrust REIT
CTRE
$7.56B
| $19.6K | ﹤0.01% |
+726
| New | +$19.6K |
|
271
National Health Investors
NHI
$3.72B
| $19.3K | ﹤0.01% |
279
-643
| -70% | -$44.6K |
|
272
Matsons
MATX
$3.36B
| $19.3K | ﹤0.01% |
143
-24
| -14% | -$3.24K |
|
273
The Ensign Group
ENSG
$10B
| $18.9K | ﹤0.01% |
142
-235
| -62% | -$31.2K |
|
274
Lantheus
LNTH
$3.72B
| $18.4K | ﹤0.01% |
+206
| New | +$18.4K |
|
275
Pennant Group
PNTG
$840M
| $17.9K | ﹤0.01% |
675
-2,709
| -80% | -$71.8K |
|